Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Net Cash Flow: 2024-2025

Historic Net Cash Flow for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to -$1.8 million.

  • Pyxis Oncology's Net Cash Flow rose 86.07% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year change of. This contributed to the annual value of $9.8 million for FY2024, which is 105.78% up from last year.
  • Pyxis Oncology's Net Cash Flow amounted to -$1.8 million in Q3 2025, which was up 7.40% from -$2.0 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Net Cash Flow ranged from a high of $18.3 million in Q1 2024 and a low of -$13.0 million during Q3 2024.
  • Over the past 2 years, Pyxis Oncology's median Net Cash Flow value was -$2.0 million (recorded in 2025), while the average stood at -$96,857.
  • Over the last 5 years, Pyxis Oncology's Net Cash Flow had its largest YoY gain of 86.07% in 2025, and its largest YoY loss of 136.68% in 2025.
  • Quarterly analysis of 2 years shows Pyxis Oncology's Net Cash Flow stood at $7.4 million in 2024, then soared by 86.07% to -$1.8 million in 2025.
  • Its Net Cash Flow was -$1.8 million in Q3 2025, compared to -$2.0 million in Q2 2025 and -$6.7 million in Q1 2025.